Skip to content

Atrial Fibrillation in Young Patients: a Prospective Multicentre Registry

Atrial Fibrillation in Young Patients: a Prospective Multicentre Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04776759
Acronym
YOUNG-AF
Enrollment
200
Registered
2021-03-02
Start date
2021-01-01
Completion date
2031-01-01
Last updated
2021-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Lone Atrial Fibrillation

Keywords

Atrial Fibrillation, Lone Atrial Fibrillation

Brief summary

Atrial fibrillation is a rare cardiac arrhythmia in young (i.e. \<= 35-year-old) patients. Etiological factors, current management and mid- to long-term outcomes remain unknown.

Detailed description

Atrial Fibrillation in YOUNG patients (YOUNG-AF) is a prospective, observational, multicentric registry, including every consecutive patients aged \< 35-year-old with a diagnosis of atrial fibrillation. The registry will assess demographical, physical activity, toxicologic and genetic factors, as well as current management regarding anticoagulation, anti-arrhythmic drugs and catheter ablation. As an observational registry, patient will be managed with the guidelines-directed standard-of-care.

Interventions

None listed

Sponsors

University Hospital, Caen
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 35 Years

Inclusion criteria

* First episode of atrial fibrillation * Less than 35-year-old * Diagnostic by 12-lead ECG or continuous monitoring (minimal duration 30 seconds) * French Social Security number

Exclusion criteria

* Transvenous cardiac implantable electronic device (insertable cardiac monitors are not an

Design outcomes

Primary

MeasureTime frameDescription
Composite of mortality, thromboembolic event and heart failureat 10-yearIncidence of all-cause mortality, symptomatic thromboembolic event and congestive heart failure at 10-year after initial diagnosis of atrial fibrillation.
Recurrent symptomatic atrial fibrillation.at 10-yearIncidence of symptomatic atrial fibrillation at 10-year after initial diagnosis of atrial fibrillation.

Countries

France

Contacts

Primary ContactPierre Ollitrault, MD, MSc
ollitrault-p@chu-caen.fr0231063106

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026